Floatz logo

Fingolimod

Cerebral Edema

Wake Forest University Health SciencesSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Cerebral Edema cohort.

Asset / SponsorPhaseRating
Sodium Aescinate
The Second Hospital of Hebei Medical University
Phase 4BB
DEXAMETHASONE
Jon Pérez Bárcena
Phase 3B
Conivaptan
Jesse Corry
Phase 2B
PANTOPRAZOLE
University of Florida
Phase 2B
Dextromethorphan
University of Florida
Phase 2B

View all 13 →

Same molecule, other indications

Fingolimod is also rated in:

relapsing-remitting multiple sclerosisDormant
A
Indicative ·
82 / 100
View asset →
multiple sclerosisDormant
BB
Indicative ·
70 / 100
View asset →
cerebral degenerationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →